# Specific Requirements on Content and Format of Labeling for Human Prescription Drugs; Addition of ``Geriatric Use'' Subsection in the Labeling
> **Food and Drug Administration** · Final rule. · Published 1997-08-27 · Effective 1998-08-27 · 62 FR 45313
## Document
- **Document number:** 97-22701
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 62 FR 45313
- **CFR reference:** 21 CFR 201
- **Publication date:** 1997-08-27
- **Effective date:** 1998-08-27
- **HHS docket:** Docket No. 89N-0474
## Abstract

The Food and Drug Administration (FDA) is amending its regulations governing the content and format of labeling for human prescription drug products, including biological products, to include information pertinent to the appropriate use of drugs in the elderly (persons aged 65 years and over) and to facilitate access to this information by establishing a ``Geriatric use'' subsection in the labeling. The final rule is one of several measures FDA has taken in response to the special concerns associated with prescription drug use in elderly patients. FDA believes that improving access to information that is important to the elderly will facilitate the safe and effective use of prescription drugs in older populations.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1997/08/27/97-22701/specific-requirements-on-content-and-format-of-labeling-for-human-prescription-drugs-addition-of)
---
*AI Analytics · CC0 1.0*